Cooper Divests Stardea To France's EA Pharma
Italian nutraceutical player Stardea has changed hands. Following six years of ownership by Cooper Consumer Health, the business has been acquired by France's EA Pharma which is keen to expand its footprint outside of its home market.
You may also be interested in...
EU Business Round-Up: EA Pharma Acquires Drasanvi, Bios Line Attracts Investment, Diapharm Sets Up Swiss Office
The latest European consumer health business news: France's EA Pharma snaps up Spain's Drasanvi; Italy's Bios Line attracts minority investment; and Diapharm sets up in Switzerland to help device manufacturers.
Cooper Consumer Health - formerly Alpha HealthGroup - said it had gained a portfolio of "high profile brands" and strengthened its position in Europe's OTC market with the acquisition of France's Tradiphar.
Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.